Venous News takes a look back at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) where Stephen Black (London, UK) and Mitchell Silver (Columbus, USA) discuss the CLEAR-DVT study.  Silver touches on some of the “historic studies” of venous intervention such as ATTRACT and CaVenT and compares them to CLEAR-DVT, which he...
Manj Gohel (Cambridge, UK) is joined by a host of venous experts including Beverley Hunt (London, UK), Stephen Black (London, UK) and Ian Franklin (London, UK) to look at the long-term impact of the COVID-19 crisis on the treatment...
Six venous specialists, Manj Gohel (Cambridge, UK), Ian Franklin (London, UK) Alun Davies (London, UK), Sriram Narayanan (Singapore), Raghu Kolluri (Columbus, USA) and Stephen Black (London, UK) discuss the role of telehealth during the COVID-19 crisis and...
Manj Gohel (Cambridge, UK), who is also a member of the CX Venous Executive Board, welcomes you to CX 2020 LIVE, which will include some of the major highlights from the deep and superficial venous programmes. A number of recently...
This video is only available in selected geographies Stephen Black (London, UK) talks to VEITHtv about how the dedicated venous open-cell nitinol Abre stent (Medtronic) compares with other venous nitinol stents available, noting that it is very easy to use,...
The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed and timely vascular and endovascular education virtual event: CX 2020 LIVE. Mark your calendars for this...
Manj Gohel (Cambridge, UK), one of the editors-in-chief of Venous News, introduces a special COVID-19 video with leading thrombosis and haemostasis experts, including Beverley Hunt (London, UK), Ian Franklin (London, UK), Francis Matthey (London, UK) and Sriram Narayanan (Singapore),...
Venous News filmed a panel discussion with Alun Davies (London, UK), Manj Gohel (Cambridge, UK) and Daniel Carradice (Hull, UK); who discussed treatment of venous ulceration and the randomised EVRA trial which, Carradice says, showed that early endovenous ablation of superficial venous...
 Michael Lichtenberg (Arnsberg, Germany) talks to BLearning Venous at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the rationale behind his team’s study which looked at Intravascular ultrasound (IVUS) compared with fluoroscopic-guided recanalisation in patients with...
 Raghu Kolluri (Columbus, USA) and John Kaufman (Portland, USA) talk to BLearning Venous about the highlights from The VEINS (Venous Endovascular INterventional Strategies) session at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA), as well as the...
Clinically relevant outcomes are needed to measure catheter-directed therapy (CDT) against anticoagulation alone to treat submassive pulmonary embolism (PE) patients. Further, CDT’s ability to affect short-term and long-term outcomes such as cardiopulmonary health after PE needs “better characterisation”, Akhilesh...
David J. Dexter, (Sentara Healthcare, Norfolk, VA, USA), principal investigator of the CLOUT registry using the ClotTriever Mechanical Thrombectomy System (Inari Medical) for treatment of acute and chronic lower extremity DVT, presented the initial results for the first 50...
 Suresh Vedantham (St Louis, USA) talks to BLearning Venous after winning the prestigious VEINS award at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) about his current take on the open vein hypothesis and more. Vedantham reflects on...
 Sanjay Misra (Rochester, USA) talks to Interventional News about his research into whether stem cell therapy can help AVFs (arteriovenous fistulas) mature and also prevent venous stenosis. The pilot study with a small group of haemodialysis AVF patients led to “promising...
 Michael Dake (Tucson, Arizona) presented the two-year data from the VERNACULAR trial at CIRSE 2019 on 8 September in Barcelona, Spain. Dake said: “The 24-month results from the VERNACULAR trial using the BD Venovo stent show absolutely sustained benefit in...
 Karen Bauer (Toledo, USA) discusses the wound care limb salvage track at C3 which offered the “opportunity for clinicians from multiple disciplines to get together and talk about some really cutting-edge” topics. Bauer, a wound specialist, says that at the...
 Rabih Chaer (Pittsburgh, USA) talks to Venous News at the Society for Vascular Surgery’s Vascular Annual Meeting (SVS VAM; 12–15 June 2019, Washington, DC, USA)about the “need for dedicated venous stents” in the US in anticipation of the recently US FDA approved...
Steven Dubenec (Sydney, Australia) and Gerard O’Sullivan (Galway, Ireland) discuss the impact of dedicated venous stents, in particular the Venovo venous stent (BD, formerly Bard) at CX 2019. Dubenec talks about how the Venovo stent – which comes in a...
 Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve. Edmonds...
 Michael D Dake (Tucson, USA) presented results from the VERNACULAR trial, which was designed to assess the performance of the Venovo venous stent (BD) for the treatment of iliac and femoral vein occlusions. At one year, the researchers found that the...
 Mahmood Razavi (Orange, USA) reported new data from a subanalysis of the VIRTUS trial, which set out to investigate the safety and efficacy of the Vici stent (Boston Scientific). The subanalysis forms part of the first prospective multicentre corelab...
 An analysis of ATTRACT has recently been published in the journal Circulation, in which the authors examine the effect of pharmacomechanical catheter-directed therapy (PCDT) in ATTRACT patients with iliofemoral deep vein thrombosis (DVT). As a result of this, Venous News spoke to...
 Venous News arranged a roundtable with Sophie Renton (London, UK), Bruce Campbell (Exeter, UK) and Manj Gohel (Cambridge, UK), who called for more high quality, medium-to-long-term evidence to support the growing use of minimally invasive, but expensive, interventions for deep...
 Kathleen Gibson (Bellevue, USA), one of the principal investigators of the SeCure trial, presented its results at the ACP 2018 annual congress. “More than closure rates, it is the quality of life findings from this trial that are important...
Rick de Graaf speaks to Venous News about complications from venous stenting, including causes and best treatment approaches for reinterventions after stenting.
Inferior vena cava (IVC) filters have long been a controversial topic, and some physicians have even called for a total moratorium on their implantation. Venous News spoke to John Kaufman (Portland, USA) at the 2017 Vascular Interventional Advances 2017...
Venous News caught up with Lars Rasmussen (Danish Vein Centres, Denmark) at the European Venous Forum (EVF; 29 June–1 July, Porto, Portugal) to hear about his five-year follow-up comparing endovenous radiofrequency ablation, laser ablation, foam sclerotherapy and surgical stripping...
At the European Venous Forum (EVF; 29 June–1 July, Porto, Portugal), Mattia Mirandola (Peschiera del Garda, Italy) presented his four-year experience of using ClariVein (Vascular Insights) for mechanochemical ablation of the saphenous vein. He shared his results with Venous...
Kathleen Gibson, Bellevue, USA, presented the three-year results of the VeClose clinical trial at the recent Charing Cross Symposium. Gibson spoke to Venous News about the study and about how she interprets the three-year data.
The pivotal VeClose trial is investigating the performance of the VenaSeal cyanoacrylate-based adhesive (Medtronic) for vein closure. At LINC 2017, Vascular News caught up with Raghu Kolluri (OhioHealth Vascular Institute, Columbus, USA) who explained his experience with the system...
Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been incorporated to the CX...
This video tells the story of one of the world’s most prominent heart surgeons, Edward Diethrich, and the career-altering health issues he has faced as a result of chronic, low-level exposure to ionising radiation through his work.
Haroun Gajraj, director of the The VeinCare Centre, Bristol, UK, speaks about using medical super glue for the treatment of varicose veins and superficial venous reflux.
https://youtu.be/ac_om5HCjvg
Raghu Kolluri vascular medicine profile

Raghu Kolluri

John-Kaufman-profile

John Kaufman

Kurosh Parsi profile

Kurosh Parsi